These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 30886845)
1. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites. Diao X; Huestis MA Front Chem; 2019; 7():109. PubMed ID: 30886845 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of third generation synthetic cannabinoids using zebrafish larvae. Morales-Noé A; Esteve-Turrillas FA; Armenta S Drug Test Anal; 2022 Apr; 14(4):594-603. PubMed ID: 34750997 [TBL] [Abstract][Full Text] [Related]
3. Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry. Watanabe S; Iwai T; Matsushita R; Nakanishi T; Kuzhiumparambil U; Fu S; Seto Y Forensic Toxicol; 2022 Jul; 40(2):278-288. PubMed ID: 36454404 [TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection. Carlier J; Diao X; Huestis MA J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040 [TBL] [Abstract][Full Text] [Related]
5. Advances in urinary biomarker research of synthetic cannabinoids. Wang Z; Leow EYQ; Moy HY; Chan ECY Adv Clin Chem; 2023; 115():1-32. PubMed ID: 37673518 [TBL] [Abstract][Full Text] [Related]
6. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Diao X; Huestis MA Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455 [TBL] [Abstract][Full Text] [Related]
7. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Diao X; Wohlfarth A; Pang S; Scheidweiler KB; Huestis MA Clin Chem; 2016 Jan; 62(1):157-69. PubMed ID: 26430074 [TBL] [Abstract][Full Text] [Related]
8. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood. Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852 [TBL] [Abstract][Full Text] [Related]
9. Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models. Dahm P; Thomas A; Rothschild MA; Thevis M; Mercer-Chalmers-Bender K Forensic Toxicol; 2022 Jul; 40(2):244-262. PubMed ID: 36454402 [TBL] [Abstract][Full Text] [Related]
10. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation. Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916 [TBL] [Abstract][Full Text] [Related]
11. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples. Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523 [TBL] [Abstract][Full Text] [Related]
12. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524 [TBL] [Abstract][Full Text] [Related]
13. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples. Franz F; Angerer V; Moosmann B; Auwärter V Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870 [TBL] [Abstract][Full Text] [Related]
14. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens. Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224 [TBL] [Abstract][Full Text] [Related]
15. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review. Navarro-Tapia E; Codina J; Villanueva-Blasco VJ; García-Algar Ó; Andreu-Fernández V Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625524 [TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry. Yeter O; Ozturk YE Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752 [TBL] [Abstract][Full Text] [Related]
17. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry. Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766 [TBL] [Abstract][Full Text] [Related]
18. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390 [TBL] [Abstract][Full Text] [Related]
19. Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans. Watanabe S; Kuzhiumparambil U; Winiarski Z; Fu S Forensic Sci Int; 2016 Apr; 261():33-42. PubMed ID: 26907475 [TBL] [Abstract][Full Text] [Related]
20. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project. Bäckberg M; Tworek L; Beck O; Helander A J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]